This case is unique because it documents a rare occurrence of a Type IV stent fracture following percutaneous coronary ...

InspireMD, Inc. (the “Company”) (Nasdaq: NSPR), developer of the CGuard Prime Carotid Stent System for the prevention of stroke, today announced that the U.S. Food and Drug Administration (FDA) has ...

The innovative product is called the Resorbable Fibrillated Scaffold (RFS). In a clinical study, doctors implanted this ...

One such innovation is the Bioresorbable Scaffold (BRS)-a temporary stent designed to restore blood flow and then dissolve, leaving the artery free of any permanent implant. “Metal stents saved lives, ...

STENTiT implanted its Resorbable Fibrillated Scaffold in the first patient enrolled in the VITAL-IT 1 study evaluating the ...

InspireMD, Inc. (the "Company") (Nasdaq: NSPR), developer of the CGuard Prime Carotid Stent System for the prevention of stroke, today announced that the U.S.

The CGuard Prime carotid stent. [Image from InspireMD] InspireMD announced that the FDA granted premarket approval (PMA) for its CGuard Prime carotid stent system. The CGuard embo ...

SNS Insider Unveils Strategic Insights into the U.S. Coronary Stent Market's Acceleration—Valued at USD 4.42 Billion in 2023—As the Nation Leads Global Adoption of Next-Gen Cardiovascular Technologies ...

Diabetes mellitus is highly prevalent in patients with coronary atherosclerosis. As a result of several factors, including a ...

A substudy reports that optical coherence tomography resulted in less vessel failure after percutaneous coronary angioplasty ...

InspireMD, Inc. announced that the FDA has granted premarket approval (PMA) of the company’s CGuard Prime carotid stent syst ...